AB Classification Study in Pediatric Diabetes (H-45745)
- To test the usefulness of new classification system in pediatric diabetes using islet autoimmunity and insulin production capacity.
- To identify biomolecular differences by fasting plasma metabolomics between type 1 diabetes and type 2 diabetes compared to healthy controls.
- 2-17 year old children with new-onset diabetes, diagnosed within last 12 weeks;
- 15-17 year old children with type 1 and type 2 diabetes, with diabetes duration between 6 months to 10 years
Investigators: Mustafa Tosur, M.D. (principal investigator), Maria J. Redondo M.D., Ph.D.(co-investigator), Serife Uysal M.D.(co-investigator), Marcela Astudillo M.D. (co-investigator)
Supported by: Texas Children's Hospital Pilot Award